|
1
|
Koppe MJ, Boerman OC, Oyen WJ and
Bleichrodt RP: Peritoneal carcinomatosis of colorectal origin:
incidence and current treatment strategies. Ann Surg. 243:212–222.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, DeSantis C, Virgo K, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu DZ, Lang NP, Thompson C, Osteen PK and
Westbrook KC: Peritoneal carcinomatosis in nongynecologic
malignancy. A prospective study of prognostic factors. Cancer.
63:364–367. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elias D, Delperro JR, Sideris L, et al:
Treatment of peritoneal carcinomatosis from colorectal cancer:
impact of complete cytoreductive surgery and difficulties in
conducting randomized trials. Ann Surg Oncol. 11:518–521. 2004.
View Article : Google Scholar
|
|
5
|
Sugarbaker PH: A curative approach to
peritoneal carcinomatosis from colorectal cancer. Semin Oncol.
32:S68–S73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Glehen O, Kwiatkowski F, Sugarbaker PH, et
al: Cytoreductive surgery combined with perioperative
intraperitoneal chemotherapy for the management of peritoneal
carcinomatosis from colorectal cancer: a multi-institutional study.
J Clin Oncol. 22:3284–3292. 2004. View Article : Google Scholar
|
|
7
|
Verwaal VJ: Long-term results of
cytoreduction and HIPEC followed by systemic chemotherapy. Cancer
J. 15:212–215. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sugarbaker PH: Peritonectomy procedures.
Surg Oncol Clin N Am. 12:703–727. xiii2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rossi CR, Mocellin S, Pilati P, et al:
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg
Oncol Clin N Am. 12:781–794. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Ruth S, Verwaal VJ and Zoetmulder FA:
Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N
Am. 12:771–780. 2003.
|
|
11
|
Klaver YL, Hendriks T, Lomme RM, Rutten
HJ, Bleichrodt RP and de Hingh IH: Hyperthermia and intraperitoneal
chemotherapy for the treatment of peritoneal carcinomatosis: an
experimental study. Ann Surg. 254:125–130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cohen MS, Al-Kasspooles MF, Williamson SK,
Henry D, Broward M and Roby KF: Combination intraperitoneal
chemotherapy is superior to mitomycin C or oxaliplatin for
colorectal carcinomatosis in vivo. Ann Surg Oncol. 17:296–303.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pelz JO, Doerfer J, Hohenberger W and
Meyer T: A new survival model for hyperthermic intraperitoneal
chemotherapy (HIPEC) in tumor-bearing rats in the treatment of
peritoneal carcinomatosis. BMC Cancer. 5:562005. View Article : Google Scholar
|
|
14
|
Bevanda M, Orsolic N, Basic I, et al:
Prevention of peritoneal carcinomatosis in mice with combination
hyperthermal intraperitoneal chemotherapy and IL-2. Int J
Hyperthermia. 25:132–140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zahedi P, De Souza R, Piquette-Miller M
and Allen C: Docetaxel distribution following intraperitoneal
administration in mice. J Pharm Pharm Sci. 14:90–99.
2011.PubMed/NCBI
|
|
16
|
Aarts F, Hendriks T, Boerman OC, Oyen WJ
and Bleichrodt RP: Hyperthermia and fibrinolytic therapy do not
improve the beneficial effect of radioimmunotherapy following
cytoreductive surgery in rats with peritoneal carcinomatosis of
colorectal origin. Cancer Biother Radiopharm. 23:301–309. 2008.
View Article : Google Scholar
|
|
17
|
Hartmann J, Kilian M, Atanassov V,
Braumann C, Ordemann J and Jacobi CA: First surgical tumour
reduction of peritoneal surface malignancy in a rat’s model. Clin
Exp Metastasis. 25:445–449. 2008.PubMed/NCBI
|
|
18
|
Bouquet W, Deleye S, Staelens S, et al:
Antitumour efficacy of two paclitaxel formulations for hyperthermic
intraperitoneal chemotherapy (HIPEC) in an in vivo rat model. Pharm
Res. 28:1653–1660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gesson-Paute A, Ferron G, Thomas F, de
Lara EC, Chatelut E and Querleu D: Pharmacokinetics of oxaliplatin
during open versus laparoscopically assisted heated intraoperative
intraperitoneal chemotherapy (HIPEC): an experimental study. Ann
Surg Oncol. 15:339–344. 2008. View Article : Google Scholar
|
|
20
|
Muller H, Hahn M, Weller L and Simsa J:
Strategies to reduce perioperative morbidity in cytoreductive
surgery. Hepatogastroenterology. 55:1523–1529. 2008.PubMed/NCBI
|
